Visualizing the evolution of abnormal metabolic networks in the brain using PET

Computerized Medical Imaging and Graphics

Volumn 19, Issue 3, 1995, Pages 295-306

  Spetsieris, Phoebe G ^a   Moeller, James R ^b   Dhawan, Vijay ^a   Ishikawa, Tatsuya ^a   Eidelberg, David ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b Department of Biological Psychiatry Columbia College of Physicians and Surgeons ^*  (United States)

Author keywords

3D Visualization; Animation; Metabolic covariance networks; Positron emission tomography (PET); Principal component analysis (PCA)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEURORADIOLOGY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALGORITHMS; BRAIN; BRAIN DISEASES; DEOXYGLUCOSE; DISEASE PROGRESSION; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE NET; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029005835     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-6111(95)00011-E     Document Type: Article

References (21)

1. Imaging cerebral function
2. Visuo-computational tools for PET physiological imaging
3. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data
4. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders A principal component approach to modeling brain function in disease
5. 18F]fluorodopa positron emission tomographic studies
6. The metabolic topography of parkinsonism
7. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET
8. The metabolic topography of idiopathic torsion dystonia
9. The metabolic pathology of the AIDS dementia complex
10. The metabolic topography of normal aging
11. Visualizing patterns of neurological disease progression with PET
12. SuperPETT 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation
13. Scanalyzer: a Unix based workstation for PET parametric imaging
14. Tomographic measurement of local cerebral metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: Validation of method
15. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlc from dynamic [18F]fluorodeoxyglucose/PET data
16. Noninvasive quantitative fluorodeoxyglucose PET studies using an estimated input function derived from a population based arterial blood curve
17. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data
18. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's Disease
19. 18F-fluorodeoxyglucose and PET
20. Positron emission tomography studies in parkinsonism
21. The relationship between global and local changes in PET scans